influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine

Trials studying influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine

• phase1A Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccineactive not recruitingn=100
• phase2A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adultscompletedn=845
• phase4Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectivelycompletedn=90
• phase4Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectivelycompletedn=90
• phase4Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectivelycompletedn=90
• phase3Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)completedn=1,928
• phase3A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Agecompletedn=1,900
• phase3A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccineactive not recruitingn=9,320